AORT Artivion
- 23.460
- -0.350-1.47%
- 23.880
- +0.420+1.79%
Artivion News
Artivion(AORT.US) Officer Sells US$29,275.13 in Common Stock
$Artivion(AORT.US)$ Officer Holloway Jean F sold 1,250 shares of common stock on May 10, 2024 at an average price of $23.4201 for a total value of $29,275.13.Source: Announcement What is statement of
Artivion(AORT.US) Officer Sells US$23,285.52 in Common Stock
$Artivion(AORT.US)$ Officer Holloway Jean F sold 979 shares of common stock on May 9, 2024 at an average price of $23.785 for a total value of $23,285.52.Source: Announcement What is statement of chan
Artivion (NYSE:AORT) Shareholder Returns Have Been Respectable, Earning 62% in 1 Year
These days it's easy to simply buy an index fund, and your returns should (roughly) match the market. But you can significantly boost your returns by picking above-average stocks. To wit, the Artivi
Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Beyond, Inc. (NYSE:BYON) fell sharply during Tuesday's session following weaker-than-expected quarterly results.Beyond posted adjusted loss of $1.22 per share, versus estimates for a loss of
Artivion | 10-Q: Quarterly report
Artivion Shares Are Trading Higher After the Company Reported a Q1 Earnings Beat and Raised the Bottom End of Its FY24 Guidance Range.
Artivion Shares Are Trading Higher After the Company Reported a Q1 Earnings Beat and Raised the Bottom End of Its FY24 Guidance Range.
Tempur Sealy Posts Upbeat Earnings, Joins FibroGen, Coca-Cola Consolidated, Fabrinet And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were higher, with the Dow Jones gaining over 80 points on Tuesday.Shares of Tempur Sealy International, Inc. (NYSE:TPX) rose sharply during Tuesday's session following upbeat quarterly ear
NanoViricides, TC BioPharm, Holdco Nuvo Among Healthcare Movers
Artivion Price Target Raised to $25.00/Share From $22.00 by Stifel
Artivion Price Target Raised to $25.00/Share From $22.00 by Stifel
Stifel: Maintaining the Artivion (AORT.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $22.00 to $25.00.
Stifel: Maintaining the Artivion (AORT.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $22.00 to $25.00.
Oppenheimer Sticks to Its Buy Rating for Artivion (AORT)
Artivion: Strong Q1 Performance and Raised Guidance Validate Buy Rating
Needham Maintains Buy on Artivion, Raises Price Target to $30
Needham analyst Mike Matson maintains Artivion (NYSE:AORT) with a Buy and raises the price target from $25 to $30.
Earnings Call Summary | Artivion(AORT.US) Q1 2024 Earnings Conference
The following is a summary of the Artivion, Inc. (AORT) Q1 2024 Earnings Call Transcript:Financial Performance:Artivion reported Q1 revenue of $97.4 million, up 16% year-on-year in constant currency.T
Artivion Inc (AORT) Q1 2024 Earnings Call Transcript Highlights: Strong Growth and Strategic ...
Artivion Inc (AORT) Surpasses Analyst Revenue Forecasts With Strong Q1 2024 Performance
Artivion Revises FY24 Revenue Guidance From 8%-12% To 9%-12% Y/Y Growth On Constant Currency Basis
The Company expects revenues to be in the range of $386 to $396 million compared to the previously articulated range of $382 to $396 million (consensus $388.028 million). At current rates, the Company
Artivion Non-GAAP EPS of $0.06 Beats by $0.04, Revenue of $97.4M Beats by $5.34M
Earnings Flash (AORT) ARTIVION Reports Q1 Revenue $97.4M, Vs. Street Est of $92.1M
04:06 PM EDT, 05/06/2024 (MT Newswires) -- Earnings Flash (AORT) ARTIVION Reports Q1 Revenue $97.4M, vs. Street Est of $92.1M
Press Release: Artivion Reports First Quarter 2024 Financial Results
Artivion Reports First Quarter 2024 Financial Results PR Newswire ATLANTA, May 6, 2024 First Quarter Highlights: -- Achieved revenue of $97.4 million in the first quarter of 2024 versus $
Analysis
Price Target
No Data
